ROLE OF LYMPHOCYTIC IMMUNOHISTOCHEMICAL MARKERS IN EARLY DIAGNOSIS OF PERIPHERAL T-CELL LYMPHOMA OF THE SKIN – MYCOSIS FUNGOIDES

Valeria Mateeva; Dimitar Tcharaktchiev; Grisha Mateev

doi:10.5272/jimab.2017233.1646

Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing
ISSN: 1312-773X (Online)
Issue: 2017, vol. 23, issue 3
Subject Area: Medicine
-
DOI: 10.5272/jimab.2017233.1646
Published online: 11 August 2017

Original article

J of IMAB 2017 Jul-Sep;23(3):1646-1650
ROLE OF LYMPHOCYTIC IMMUNOHISTOCHEMICAL MARKERS IN EARLY DIAGNOSIS OF PERIPHERAL T-CELL LYMPHOMA OF THE SKIN – MYCOSIS FUNGOIDES
Valeria Mateeva¹ , Dimitar Tcharaktchiev², Grisha Mateev³,
1) Department of Dermatology and Venereology, Military Medical Academy, Sofia, Bulgaria
2) Clinical Centre of Endocrinology and Gerontology, Medical Faculty, Medical University, Sofia, Bulgaria
3) Department of Dermatology and Venereology, Medical Faculty, Medical University, Sofia, Bulgaria.

ABSTRACT:
Background: Mycosis fungoides (MF) is the most common type of primary cutaneous peripheral T-cell lymphoma. The diagnosis of early-stage MF is challenging due to its clinical and histological resemblance to a number of benign inflammatory dermatoses. Often an immunohistochemical phenotyping is required for the diagnosis.
Purpose: To assess the diagnostic value of a panel of seven lymphocytic immunohistochemical markers (CD3; CD20; CD4; CD8; CD45RO; CD30; Bcl2) in the early diagnosis of MF.
Material/Methods: Biopsies from 30 patients with confirmed early-stage MF were stained with lymphocytic markers: CD3; CD20; CD4; CD8; CD45RO; CD30; Bcl2. The epidermal and dermal expression in this group was compared with a control group of 30 cases of benign inflammatory dermatoses, which clinically resemble MF.
Results: A statistically significant difference was found in the expression of CD3, CD4, CD8, CD45RO and Bcl2 in the epidermis between the two groups and the expression of CD3, CD4, CD8, CD45RO and CD30 in the dermal infiltrate. There was no statistically significant difference in the expression of CD20 and Bcl2 in the dermal infiltrate between the two groups.
Conclusions: There is no single marker that has enough sensitivity and specificity to be used independently for the diagnosis of MF. High epidermal expression of CD3, CD4, and CD45RO by infiltrating lymphocytes is diagnostic for MF. The most sensitive marker for MF is the CD4/CD8 ratio in the dermal infltrate; it takes into account the statistically different expression of CD4 and CD8 in both groups.

Keywords: cutaneous T-cell lymphoma, mycosis fungoides, immunohistochemistry,

- Download FULL TEXT /PDF 495 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Mateeva V, Tcharaktchiev D, Mateev G . Role of lymphocytic immunohistochemical markers in early diagnosis of peripheral T-cell lymphoma of the skin – mycosis fungoides. J of IMAB. 2017 Jul-Sep;23(3):1646-1650. DOI: 10.5272/jimab.2017233.1646

Correspondence to: Valeria Mateeva, Department of Dermatology and Venereology, Military Medical Academy, Sofia; 3, St. Georgi Sofiiski Blvd., 1606 Sofia, Bulgaria; E-mail: vali_mateeva@hotmail.com

REFERENCES:
1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005 May;105(10):3768-85. [PubMed] [CrossRef]
2. Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol 2014 Feb;70(2): 205 e1-16; quiz 221-2. [PubMed] [CrossRef]
3. Reddy K, Bhawan J. Histologic mimickers of mycosis fungoides: a review. J Cutan Pathol 2007 Jul:34(7):519-25. [PubMed] [CrossRef]
4. Ralfkiaer E. Immunohistological markers for the diagnosis of cutaneous lymphomas. Semin Diagn Pathol. 1991;8(2):62-72. [PubMed]
5. Bosisio FM, Cerroni L. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas. Am J Dermatopathol. 2015 Feb;37(2):115-21. [PubMed] [CrossRef]
6. Burg G, Kempf W, Cozzio A, Feit J, Willemze R, Jaffe E, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol. 2005 Nov;32(10):647-74. [PubMed] [CrossRef]
7. Haynes BF, Hensley LL, Jegasothy BV. Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates. Blood. 1982 Aug;60(2):463-73. [PubMed]
8. Scarisbrick JJ, Kim YH, Whittaker SJ, Wood GS, Vermeer MH, Prince HM, et al. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sezary syndrome: where are we now? Br J Dermatol. 2014 Jun;170(6):1226-36. [PubMed] [CrossRef]
9. Ishida M, Okabe H. Reactive lymphoid follicles with germinal centers in granulomatous mycosis fungoides: a case report with review of the literature. J Cutan Pathol. 2013 Feb;40(2):284-5.. [PubMed] [CrossRef]
10. Asadullah K, Friedrich M, Docke WD, Jahn S, Volk HD, Sterry W. Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma. J Invest Dermatol. 1997 May;108(5):743-7. [PubMed]
11. Ormsby A, Bergfeld WF, Tubbs RR, Hsi ED. Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: implications for diagnosis of mycosis fungoides in community clinical practice. J Am Acad Dermatol. 2001 Sep;45(3):405-413. [PubMed] [CrossRef]
12. Whitling NA, Shanesmith RP, Jacob L, McBurney E, Sebastian S, Wang E, et al. Composite lymphoma of mycosis fungoides and cutaneous small B-cell lymphoma in a 73-year-old male patient. Hum Pathol. 2013 Apr;44(4):670-5. [PubMed] [CrossRef]
13. Edinger JT, Clark BZ, Pucevich BE, Geskin LJ, Swerdlow SH. CD30 expression and proliferative fraction in nontransformed mycosis fungoides. Am J Surg Pathol. 2009 Dec;33(12):1860-8. [PubMed] [CrossRef]
14. Kari L, Loboda A, Nebozhyn M, Rook AH, Vonderheid EC, Nichols C, et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med. 2003 Jun;197(11):1477-88. [PubMed] [CrossRef].

Received: 22 May 2017
Published online: 11 August 2017

back to Online Journal